Development of a rhenium-186-labeled MAG3-conjugated bisphosphonate for the palliation of metastatic bone pain based on the concept of bifunctional radiopharmaceuticals.

Source:http://linkedlifedata.com/resource/pubmed/id/16029015

Download in:

View as

General Info

PMID
16029015